Skip to main content
Premium Trial:

Request an Annual Quote

IP Watch: Qiagen, Hologic, Micronics, Others Win US Patents

Premium

EMD Millipore has been awarded US Patent No. 8,765,054, "Process for treatment of residual nucleic acids present on the surface of laboratory consumables."

Marie Pressel and Didier Metz are named as inventors.


The University of Toledo has been awarded US Patent No. 8,765,368, "Cancer risk biomarker."

James Willey, Thomas Blomquist, Erin Crawford, and D'Anna Mullins are named as inventors.


Analytik Jena has been awarded US Patent No. 8,765,371, "Method for the in vitro detection and differentiation of pathophysiological conditions."

Stefan Russwurm is named as the inventor.


454 Life Sciences has been awarded US Patent No. 8,765,380, "Bead emulsion nucleic acid amplification."

Jan Berka, Yi-Ju Chen, John Leamon, Steve Lefkowitz, Kenton Lohman, Vinod Makhijani, Jonathan Rothberg, Gary Sarkis, Maithreyn Srinivasan, and Michael Weiner are named as inventors.


Ganymed Pharmaceuticals has been awarded US Patent No. 8,765,389, "Genetic products which are differentially expressed in tumors and use thereof."

Oezlem Tuereci, Ugur Sahin, and Michael Koslowski are named as inventors.


Third Wave Technologies has been awarded US Patent No. 8,765,418, "Detection of HPV."

Angela Hudson, Tamara Sander, Poonam Agarwal, Michelle Garsha, Hon Ip, Robert Kwiatkowski, Vecheslav Elagin, Marilyn Olson-Munoz, Michelle Curtis, Sarah Olson, and Ilse Tyler are named as inventors.


Gen-Probe (Hologic) has been awarded US Patent No. 8,765,652, "Method of making a formulation for deactivating nucleic acids."

Norman Nelson, Kenneth Browne, Lizhong Dai, James Russell, Mark Filipowsky, Margarita Kaminsky, and Daniel Kacian are named as inventors.


Institut National de la Sante et de la Recherche Medicale (INSERM) and
The Nice Sophia Antipolis University have been awarded US Patent No. 8,771,937, "Methods for diagnosing and treating a pathology associated with a synonymous mutation occurring within a gene of interest."

Patrick Brest, Paul Hofman, and Baharia Mograbi are named as inventors.


University of Notre Dame has been awarded US Patent No. 8,771,938, "Microfluidic platforms for multi-target detection."

Hsueh-Chia Chang, Jason Gordon, Satyajyoti Senpati, Zachary Gagnon, and Sagnik Basuray are named as inventors.


Epigenomics has been awarded US Patent No. 8,771,939, "Method for methylation analysis of nucleic acid."

Reimo Tetzner and Joern Lewin are named as inventors.


Sequenom has been awarded US Patent No. 8,771,948, "Nucleic acid preparation compositions and methods."

Michele Wisniewski, William Kwong, Firouz Mohsenian, and Jian-Hua Ding are named as inventors.


The President and Fellows of Harvard College have been awarded US Patent No. 8,771,950, "Methods for making nucleotide probes for sequencing and synthesis."

George Church, Kun Zhang, and Joseph Chou are named as inventors.


Genomics USA has been awarded US Patent No. 8,771,951, "Methods for PCR and HLA typing using raw blood."

Michael Hogan, Georgina Padilla, Melissa May, Andrew Abalos, Frederick Eggars, and Kevin O'Brien are named as inventors.


Qiagen has been awarded US Patent No. 8,771,952, "Substances and methods for a DNA based profiling assay."

Manja Bohme, Jorg Gabert, and Werner Brabetz are named as inventors.


Blood Cell Storage has been awarded US Patent No. 8,771,955, "Device and method for extraction and analysis of nucleic acids from biological samples."

Michael Reed and Oliver Nanassy are named as inventors.


Micronics has been awarded US Patent No. 8,772,017, "Integrated nucleic acid assays."

Frederick Battrell, John Gerdes, John Williford, Denise Hoekstra, Wayne Breidford, Stephen Mordue, John Clemmens, Melud Nabavi, and Mark Kokoris are named as inventors.


California Institute of Technology has been awarded US Patent No. 8,772,464, "Aptamer regulated nucleic acids and uses thereof."

Christina Smolke and Travis Bayer are named as inventors.


Rosalind Franklin University of Medicine and Science has been awarded US Patent No. 8,772,468, "Splice variant specific messenger RNA transcripts as biomarkers of Parkinson's disease."

Judith Potashkin is named as the inventor.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.